Effects of the hepatocarcinogen 2-acetylaminofluorene on insulin binding to microsomal and golgi fractions of rat liver cells

Arye Lev-Ran, Zeev Josefsberg, Brian I. Carr, Gegham Barseghian, David Hwang

Research output: Contribution to journalArticlepeer-review

Abstract

Adult male Fischer rats fed the hepatocarcinogen 2-acetylaminofluorene [(2-AAF) CAS: 53-96-3; N-fluoren-2-yl-aceta-mide] at 0.02% showed a sharp decrease in the insulin binding to the Golgi fraction of the liver cells: From 10.0% specific binding per 0.1 mg protein in control animals to 5.9% after only 2 days and to 1.5% after 21 days of feeding 2-AAF. A less pronounced and slower decrease was observed in the microsomal fraction: From 19.1% specific binding per 0.5 mg protein in controls to a nadir of 10.8% after 46 days. The low binding of insulin to both fractions was observed for the 85 days of the experiment and persisted also in the animals fed 2-AAF for 90–107 days and then taken off the carcinogen for 30–75 days. The decrease in binding was due to the apparent decrease in the number of receptors. Neither 2-AAF nor its metabolites N-hydroxy-2-AAF (CAS: 53-95-2; N-fluoren-2-yl-acetohydroxamic acid) and N-acetoxy-2-AAF (CAS: 6098-44-8; N, O-diacetyl-N-fluoren-2-yl-hydroxylamine) influenced the insulin binding to the microsomes when added to the reaction mixture in vitro.

Original languageEnglish
Pages (from-to)505-509
Number of pages5
JournalJournal of the National Cancer Institute
Volume73
Issue number2
DOIs
Publication statusPublished - 1984

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Fingerprint Dive into the research topics of 'Effects of the hepatocarcinogen 2-acetylaminofluorene on insulin binding to microsomal and golgi fractions of rat liver cells'. Together they form a unique fingerprint.

Cite this